Akcea Therapeutics shakes up executive suite, board in 'disconcerting' move

One of Akcea Therapeutics' biggest shareholders has instituted a shake-up at the Boston biotech, replacing longtime CEO Paula Soteropoulos and two other executives in a surprising move.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.